Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

6.7%

2 terminated/withdrawn out of 30 trials

Success Rate

91.3%

+4.8% vs industry average

Late-Stage Pipeline

7%

2 trials in Phase 3/4

Results Transparency

10%

2 of 21 completed trials have results

Key Signals

1 recruiting2 with results

Enrollment Performance

Analytics

N/A
17(81.0%)
Phase 4
2(9.5%)
Phase 1
1(4.8%)
Early Phase 1
1(4.8%)
21Total
N/A(17)
Phase 4(2)
Phase 1(1)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (30)

Showing 20 of 30 trials
NCT06278181Completed

Diabetes, Metabolic Syndrome and Risk of Malaria in Cameroon

Role: collaborator

NCT06603792Early Phase 1Recruiting

Neurofeedback for the Management of Neuropathic Pain in People with Diabetes

Role: collaborator

NCT06007157Not ApplicableUnknown

Sodium Glucose Cotransporter-2 Inhibitors and Salt-sensitivity in Type 2 Diabetes

Role: collaborator

NCT03415880Not ApplicableCompleted

Light Intensity Physical Activity Trial

Role: collaborator

NCT00179777Not ApplicableCompleted

TRIGR - Primary Prevention Study for Type 1 Diabetes in Children at Risk

Role: collaborator

NCT03441919Completed

Activation Innate Immune System in Type 1 Diabetes

Role: collaborator

NCT02475421Not ApplicableCompleted

Hyperglucagonaemia in Patients With Type 2 Diabetes - Role of Glucagon Clearance

Role: collaborator

NCT01159847Phase 1Completed

Protective Effects of Sitagliptin on β Cell Function in Patients With Adult-onset Latent Autoimmune Diabetes (LADA)

Role: lead

NCT02397421Phase 4Completed

Safety and Effectiveness of SGLT-2 Inhibitors in Patients With Heart Failure and Diabetes

Role: collaborator

NCT03555734Unknown

Umbrella Review and Updated Systematic Review and Meta-analysis of Pulses/Legumes and Incident Cardiometabolic Diseases

Role: collaborator

NCT02072902Completed

Diabetes, Glucose Control, Glucose Lowering Medications, and Cancer Risk: A 10-year Population-based Historical Cohort

Role: collaborator

NCT03286816Not ApplicableCompleted

The Effect of Intravenous Lactate on Brain Lactate Concentrations During Hypoglycemia

Role: collaborator

NCT02497651Not ApplicableCompleted

Effect of Smoking on Postprandial Gastric Emptying, Glucose Tolerance and Secretion of Gut and Pancreatic Hormones

Role: collaborator

NCT02003274Not ApplicableUnknown

Mixed Meal Test in Type 1 Diabetes on Insulin Pump Therapy: Optimization of Artificial Pancreas

Role: collaborator

NCT01861756Not ApplicableCompleted

The Diabetes Medication Choice Cards Trial in Greece

Role: collaborator

NCT02308293Not ApplicableCompleted

The Role of Endogenous Lactate in Brain Preservation and Counterregulatory Defenses Against Hypoglycemia

Role: collaborator

NCT01073826Not ApplicableCompleted

Role of Interleukin-6 in Exercise

Role: collaborator

NCT02072759Not ApplicableCompleted

Acetylcarnitine and Metabolic Flexibility

Role: collaborator

NCT01858506Not ApplicableCompleted

Diabetes Lifestyle Assessment and Educational Tools

Role: collaborator

NCT02006459Completed

Involvement of Extrapancreatic Factors on Gastrointestinal-mediated Glucose Disposal

Role: collaborator